Citigroup’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-22,867
Closed -$94K 6055
2022
Q1
$94K Sell
22,867
-33,725
-60% -$139K ﹤0.01% 3760
2021
Q4
$202K Sell
56,592
-7,907
-12% -$28.2K ﹤0.01% 3601
2021
Q3
$235K Buy
64,499
+47,893
+288% +$174K ﹤0.01% 3315
2021
Q2
$72K Buy
16,606
+4,085
+33% +$17.7K ﹤0.01% 3983
2021
Q1
$51K Sell
12,521
-21,149
-63% -$86.1K ﹤0.01% 4043
2020
Q4
$134K Buy
33,670
+24,131
+253% +$96K ﹤0.01% 3487
2020
Q3
$26K Sell
9,539
-40,132
-81% -$109K ﹤0.01% 3812
2020
Q2
$137K Buy
49,671
+3,012
+6% +$8.31K ﹤0.01% 3275
2020
Q1
$110K Sell
46,659
-117,262
-72% -$276K ﹤0.01% 3241
2019
Q4
$770K Buy
163,921
+143,579
+706% +$674K ﹤0.01% 2368
2019
Q3
$68K Sell
20,342
-24,819
-55% -$83K ﹤0.01% 3631
2019
Q2
$149K Buy
45,161
+1,840
+4% +$6.07K ﹤0.01% 3380
2019
Q1
$132K Buy
43,321
+7,854
+22% +$23.9K ﹤0.01% 3396
2018
Q4
$96K Sell
35,467
-4,228
-11% -$11.4K ﹤0.01% 3521
2018
Q3
$134K Sell
39,695
-6,042
-13% -$20.4K ﹤0.01% 3397
2018
Q2
$119K Buy
45,737
+3,194
+8% +$8.31K ﹤0.01% 3309
2018
Q1
$94K Buy
42,543
+3,096
+8% +$6.84K ﹤0.01% 3415
2017
Q4
$78K Buy
39,447
+38,995
+8,627% +$77.1K ﹤0.01% 3566
2017
Q3
$1K Sell
452
-495
-52% -$1.1K ﹤0.01% 4645
2017
Q2
$3K Buy
+947
New +$3K ﹤0.01% 4484
2016
Q4
Sell
-6,162
Closed -$10K 5005
2016
Q3
$10K Sell
6,162
-2,200
-26% -$3.57K ﹤0.01% 4463
2016
Q2
$9K Sell
8,362
-129,428
-94% -$139K ﹤0.01% 4568
2016
Q1
$120K Buy
137,790
+75,259
+120% +$65.5K ﹤0.01% 3840
2015
Q4
$75K Buy
62,531
+44,460
+246% +$53.3K ﹤0.01% 3797
2015
Q3
$31K Sell
18,071
-96,002
-84% -$165K ﹤0.01% 3801
2015
Q2
$237K Buy
114,073
+10,344
+10% +$21.5K ﹤0.01% 2635
2015
Q1
$281K Sell
103,729
-18,734
-15% -$50.8K ﹤0.01% 2685
2014
Q4
$314K Buy
122,463
+7,748
+7% +$19.9K ﹤0.01% 2825
2014
Q3
$210K Buy
114,715
+18,729
+20% +$34.3K ﹤0.01% 2616
2014
Q2
$256K Sell
95,986
-24,963
-21% -$66.6K ﹤0.01% 2393
2014
Q1
$424K Sell
120,949
-31,118
-20% -$109K ﹤0.01% 2223
2013
Q4
$680K Buy
152,067
+53,246
+54% +$238K ﹤0.01% 2129
2013
Q3
$402K Buy
98,821
+1,414
+1% +$5.75K ﹤0.01% 2121
2013
Q2
$406K Buy
+97,407
New +$406K ﹤0.01% 2212